» Articles » PMID: 24419059

CBP-mediated FOXO-1 Acetylation Inhibits Pancreatic Tumor Growth by Targeting SirT

Overview
Journal Mol Cancer Ther
Date 2014 Jan 15
PMID 24419059
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Here, we investigated the potential mechanism of capsaicin-mediated apoptosis in pancreatic cancer cells. Capsaicin treatment phosphorylated c-jun-NH2-kinase (JNK); forkhead box transcription factor, class O (FOXO1); and BIM in BxPC-3, AsPC-1, and L3.6PL cells. The expression of BIM increased in response to capsaicin treatment. Capsaicin treatment caused cleavage of caspase-3 and PARP, indicating apoptosis. Antioxidants tiron and PEG-catalase blocked capsaicin-mediated JNK/FOXO/BIM activation and protected the cells from apoptosis. Furthermore, capsaicin treatment caused a steady increase in the nuclear expression of FOXO-1, leading to increased DNA binding. Capsaicin-mediated expression of BIM was found to be directly dependent on the acetylation of FOXO-1. The expression of CREB-binding protein (CBP) was increased, whereas SirT-1 was reduced by capsaicin treatment. Using acetylation mimic or defective mutants, our result demonstrated that phosphorylation of FOXO-1 was mediated through acetylation by capsaicin treatment. JNK inhibitor attenuated the phosphorylation of FOXO-1, activation of BIM, and abrogated capsaicin-induced apoptosis. Moreover, silencing FOXO1 by siRNA blocked capsaicin-mediated activation of BIM and apoptosis, whereas overexpression of FOXO-1 augmented its effects. Silencing Bim drastically reduced capsaicin-mediated cleavage of caspase-3 and PARP, indicating the role of BIM in apoptosis. Oral administration of 5 mg/kg capsaicin substantially suppressed the growth of BxPC-3 tumor xenografts in athymic nude mice. Tumors from capsaicin-treated mice showed an increase in the phosphorylation of JNK, FOXO-1, BIM, and levels of CBP, cleavage of caspase-3, PARP, and decreased SirT-1 expression. Taken together, our results suggest that capsaicin activated JNK and FOXO-1, leading to the acetylation of FOXO-1 through CBP and SirT-1. Acetylated FOXO1 induced apoptosis in pancreatic cancer cells through BIM activation.

Citing Articles

Apoptotic vesicles derived from bone marrow mesenchymal stem cells increase angiogenesis in a hind limb ischemia model via the NAMPT/SIRT1/FOXO1 axis.

Chen J, Shen Z, Chen B, Liu S, Mei Y, Li K Stem Cell Res Ther. 2025; 16(1):105.

PMID: 40025506 PMC: 11872336. DOI: 10.1186/s13287-025-04245-1.


The role of acetylation and deacetylation in cancer metabolism.

Wang C, Ma X Clin Transl Med. 2025; 15(1):e70145.

PMID: 39778006 PMC: 11706801. DOI: 10.1002/ctm2.70145.


Forkhead box O proteins: steering the course of stem cell fate.

Cheng M, Nie Y, Song M, Chen F, Yu Y Cell Regen. 2024; 13(1):7.

PMID: 38466341 PMC: 10928065. DOI: 10.1186/s13619-024-00190-1.


FoxO1 promotes ovarian cancer by increasing transcription and METTL14-mediated mA modification of SMC4.

Tan L, Wang S, Huang S, Tie Y, Sai N, Mao Y Cancer Sci. 2024; 115(4):1224-1240.

PMID: 38403332 PMC: 11006996. DOI: 10.1111/cas.16120.


Acetylation of FOXO1 activates Bim expression involved in CVB3 induced cardiomyocyte apoptosis.

Hu Y, Yi L, Yang Y, Wu Z, Kong M, Kang Z Apoptosis. 2023; 29(7-8):1271-1287.

PMID: 38127284 PMC: 11263423. DOI: 10.1007/s10495-023-01924-3.


References
1.
YUN T . Update from Asia. Asian studies on cancer chemoprevention. Ann N Y Acad Sci. 2000; 889:157-92. DOI: 10.1111/j.1749-6632.1999.tb08734.x. View

2.
van der Horst A, Tertoolen L, de Vries-Smits L, Frye R, Medema R, Burgering B . FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem. 2004; 279(28):28873-9. DOI: 10.1074/jbc.M401138200. View

3.
Glauser D, Schlegel W . The emerging role of FOXO transcription factors in pancreatic beta cells. J Endocrinol. 2007; 193(2):195-207. DOI: 10.1677/JOE-06-0191. View

4.
Sahu R, Srivastava S . The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. J Natl Cancer Inst. 2009; 101(3):176-93. PMC: 2724856. DOI: 10.1093/jnci/djn470. View

5.
Huang H, Tindall D . Dynamic FoxO transcription factors. J Cell Sci. 2007; 120(Pt 15):2479-87. DOI: 10.1242/jcs.001222. View